Bright Angel Therapeutics
ON - TorontoBiotechnology
Focus: Bright Angel Therapeutics is a Toronto-based biotechnology company focused on novel therapeutics for drug-resistant and life-threatening fungal infections. The company operates in a specialized infectious disease niche with limited public visibility.
Profile data last refreshed 3h ago · AI intelligence enriched 2mo ago
Open Jobs
14+13 this month
Growing — net +13 jobs in 30d
13 jobs added vs 0 removed. Steady team buildout.
Should You Work at Bright Angel Therapeutics?
AI assessmentBright Angel is a high-risk, mission-driven early-stage bet suitable only for scientists seeking ownership equity upside and tolerance for extended runway uncertainty.
Why Work Here
- Focused mission on underserved fungal infection space with significant unmet medical need and less competitive talent landscape
- Early-stage biotech environment enables broad skill application and accelerated learning in drug development
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Bright Angel Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.